Polypharmacy in the Elderly

Authors

  • Kate L. Szymanski, DO Department of Family Medicine and Geriatrics, University of Toledo, Toledo, OH
  • Anu Garg, MD, CMD Department of Family Medicine and Geriatrics, University of Toledo, Toledo, OH
  • Megan Sizemore, RPh, PharmD, BCACP, BCMTMS Department of Family Medicine and Geriatrics, University of Toledo, Toledo, OH
  • Lindsey Loutzenhiser, BSPS University of Toledo College of Pharmacy, Toledo, OH

DOI:

https://doi.org/10.33181/13089

Abstract

Polypharmacy is the regular use of multiple medications and is often seen in older adults and individuals with multiple comorbidities. The commonly accepted definition of polypharmacy is the use of five or more medications by any individual. As patients become more multimorbid, the use of medication therapy increases and in turn raises the risk of polypharmacy. Polypharmacy is often associated with adverse outcomes, including increased mortality, falls, drug interactions, drug reactions, increased length of stay in the hospital, and increased readmission to the hospital after discharge. Patients over the age of 65 are often not included or well represented in drug trials, which can make medical decision-making challenging for evaluation of risk versus benefit in this patient population. There are several important factors to take note of when evaluating patients with polypharmacy.

Downloads

Published

2022-11-30

How to Cite

Szymanski, Kate L., et al. “Polypharmacy in the Elderly”. Osteopathic Family Physician, vol. 14, no. 6, Nov. 2022, pp. 25–28, doi:10.33181/13089.